Open Access
Research Paper
Peer Reviewed

Paper Title

DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.

Article Identifiers

Registration ID: IJNRD_308751

Published ID: IJNRD2508045

: Click Here to Get

About Hard Copy and Transparent Peer Review Report

Keywords

DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.

Abstract

Rheumatoid Arthritis (RA) is auto immune disorder causes inflammation in joints resulting pain & deformity in wrist, fingers and ankles. This disease arises in women more than men at any age. The manifestation of disease includes redness, inflammation.[1] Early diagnosis is important for improvement of symptoms but quite difficult to detect at early age as it depends upon gathering clinical information & history of patient. There is no permanent therapy to treat rheumatoid arthritis. For complete suppression of disease symptoms, rheumatologist need to observe activity constantly and correctly to adjust treatment schedule. From last 20 years, Disease modifying anti-rheumatoid drugs (DMARDs) has gained much attention because of their effectiveness and can efficiently reduce the activity of disease and considerably decrease the joint deformity. In current therapies DMARDS are rarely implemented for the treatment of disease. Several new biological DMARDS such as anti-CD20 antibody, TNF inhibitors etc. With increase in the number of drugs and treatment options available, the long term disease remission is not achieved in many cases and thus new therapeutic options are still needed.[2,3] The reason of occurring the rheumatoid arthritis is not clear till date, it is supposed that the disease occurs due to various genetic and environment factors. The disease causes the inflammation and thickening of the joint which occurs due to the immature system of the body directly attacking the joints. The disease may also result in low blood cell count, inflammation nearby the lungs and heart.

How To Cite (APA)

Masood Iftikhar, Dr. Praveen Kumar, & Kritika Badola (August-2025). DEVELOPMENT AND IN-VITRO CHRATERIZATION OF CUBOSOMAL GEL FOR TOPICAL DELIVERY OF CELECOXIB FOR TREATMENT OF RHEUMATOID ARTHRITIS.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 10(8), a448-a455. https://ijnrd.org/papers/IJNRD2508045.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_308751

Published Paper Id: IJNRD2508045

Research Area: Science and Technology

Author Type: Indian Author

Country: -, -, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2508045.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2508045

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

ยฉ 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). ๐Ÿ›ก๏ธ Disclaimer: The content, data, and findings in this article are based on the authorsโ€™ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use. CC OpenContant

Publication Timeline

Paper Submission
26-07-2025
Peer Review
Through Scholar9.com Platform
Paper Acceptance
02-08-2025
Paper Publication
07-08-2025

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 11 | Issue 2 | February 2026

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.

For Indian Authors : Get a transparent peer review report from Scholar9.com for just โ‚น1000. View Sample Report

For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report


Transparent Peer Review Journal Publication


โญ Transparent Peer Review | ๐Ÿ•ต๏ธโ€โ™‚๏ธ Double-Blind | ๐Ÿ‘จโ€๐Ÿซ 3000+ Expert Reviewers | ๐Ÿ‡ฎ๐Ÿ‡ณ Report for India Author โ‚น1000 | ๐ŸŒ Report for Foreign Author $20 | ๐Ÿ“„ Sample Reports on Scholar9.com | ๐ŸŒ High Credibility | โš–๏ธ Ethical & Unbiased Evaluation

How to submit the paper?

Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.


You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.


For more details, refer to the official notice: UGC Public Notice


โญ Low Cost โ‚น1570 | ๐Ÿ“š UGC CARE Approved | ๐Ÿ” Peer-Reviewed | ๐ŸŒ Open Access | ๐Ÿ”— Crossref DOI & Global Indexing | ๐Ÿ“Š Google Scholar Impact Factor | ๐Ÿงช Multidisciplinary


Submit Paper Online  Call for Paper  About IJNRD UGC CARE Approval

Important Dates for Current issue

Paper Submission Open For: February 2026

Current Issue: Volume 11 | Issue 2 | February 2026

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Mar-2026

Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.

Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.

Subject Category: Research Area

Approval, Licenses and Indexing: More Details


Call For Paper - Volume 11 | Issue 2 | February 2026


IJNRD.org offers low-cost journal publication starting at โ‚น1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.


Volume 11 | Issue 2 | February 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online


โญ UGC CARE Approved Refereed Journal | ๐Ÿ” Transparent Peer Review | ๐ŸŒ Open Access Publishing | ๐Ÿ’ฐ Low-Cost โ‚น1570 | ๐Ÿ”— CrossRef DOI & Global Indexing | ๐Ÿ“Š Google Scholar Impact Factor 8.76 | ๐Ÿงช Multidisciplinary | Online & Print


Submit Paper Online